Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.63663 | 26 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.60438 | 26 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.61375 | 27 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.55771 | 26 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.545 | 26 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.98754 | 39 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.62632 | 25 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.68163 | 31 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.55845 | 25 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.58033 | 26 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.61384 | 27 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.58262 | 27 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.57988 | 25 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.5986 | 26 |